Learn More
Medchemexpress LLC DAPT | 208255-80-5 | 100.0% | 200 MG

Supplier: Medchemexpress LLC HY13027200MG
DAPT is a potent and orally active γ-secretase inhibitor. It inhibits the activation of Notch 1 signaling and induces cell differentiation, autophagy, and apoptosis. This compound exhibits neuroprotection activity and holds potential for the treatment of autoimmune and lymphoproliferative diseases, degenerative diseases, and various cancers.
- Inhibits γ-secretase with IC50s of 115 nM for total amyloid-β (Aβ) and 200 nM for Aβ42.
- Inhibits activation of Notch 1 signaling.
- Induces cell differentiation, autophagy, and apoptosis.
- Exhibits neuroprotection activity, particularly in cerebral ischemia models.
- Potential therapeutic agent for autoimmune and lymphoproliferative diseases.
- Potential therapeutic agent for degenerative diseases and cancers.
- Useful in research for Alzheimer's disease, cell differentiation, autophagy, and apoptosis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.